Pricing Log in Create free account
Saturday 17 October 2026 Export SGRX’s income statement to Excel — free account

SANGRIX Inc.

SGRX Financial Financial Data & Stock Exchanges

0.87 0.18 +26.09%
Market cap
$1.3M
P/E
0.0×
Fwd P/E
−1.1×
Dividend yield
—
F-score
5/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 72.04%

Capital & Financial Ratios $m

Market Cap 1.31
Revenue 121.10
Net Income (34.11)
Free Cash Flow (15.23)
Net Debt 5.67
Current Ratio 44.94
Debt/Equity (8.00)
P/E ratio 0.00
Fwd P/E (1.14) (negative: loss-making)
P/S ratio 0.00
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth —
Next Y EPS Growth —
Next Y revenue growth —
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2021 Powerpack
2020 Powerpack
2019 Powerpack
2018 Powerpack
2016 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 2026
Cash 2 2 0 7
Receivables 0 5 3 3
Inventory — — — —
Other 1 — — —
4 7 4 10
2023 2024 2025 2026
Payables 1 — — —
ST’ Debt 2 2 — —
Other — — — —
3 2 0 1

Compound Annual Growth %

10y 5y 3y
Sales — (72.31%) (41.01%)
Cash Flow 0.00% 0.00% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value (4.25%) 0.00% (21.96%)

Revenue $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — 0
’24 — — — — 3
’23 — — — — 6
’22 — — — — 0
’21 — — — — 80
’20 — — — — 24
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’26 — — — — (3)
’25 — — — — (2)
’24 — — — — (8)
’23 — — — — (7)
’22 — — — — (14)
’21 — — — — (11)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’26 — — — (2) (3)
’25 — (2) — (3) (2)
’24 — (3) — 0 (3)
’23 — (2) — (3) (2)
’22 — (23) — (7) (23)
’21 — (11) — (11) (11)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 — — — — —
’26 — — — — (70.43)
’25 — — — — (83.83)
’24 — — — — (1.00k)
’23 — — — — (2.55k)
’22 — — — — 449.10
’21 — — — — (12.41k)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to June

Group Line 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Trend 2027e 2028e 2029e
Price, $
Price, $ Low — — 7,380.00 5,580.00 6,660.00 1,278.00 375.00 243.00 35.40 0.56

Analyst estimates 2027–2029

Powerpack
High — — 45,000.00 42,660.00 28,080.00 13,950.00 3,780.00 2,913.00 321.00 63.60
People
People Employees — 200 178 154 24 11 9 5 5 5
Revenue/emp, $m 0.00 0.51 0.56 0.16 3.35 0.02 0.70 0.58 0.01 0.00
Income, $m
Income, $m Revenue 63 101 99 24 80 0 6 3 0 —
Gross margin, % 8.01 9.55 8.73 8.37 3.72 (109.67) (72.92) (32.72) 100.00 —
EBT 3 4 5 (3) (4) (5) (28) (18) (4) (14)
EBT margin, % 5.26 4.43 5.29 (12.96) (4.52) (2,776.87) (450.66) (633.03) (11,063.04) 0.00
Net income 0 4 5 (3) (4) (5) (28) (18) (4) (14)
Depreciation 1 1 1 0 0 0 6 2 1 —
Per share, $
Per share, $ Revenue 2.66 45,956.45 43,077.96 9,699.52 21,756.32 28.72 569.19 165.06 0.51 0.00
Earnings 0.10 1,693.96 1,888.12 (1,979.04) (12,407.62) 449.10 (2,544.91) (1,000.00) (83.83) (70.43)
Cash flow (0.11) (1,634.09) (2,290.13) (2,364.80) (2,849.68) (2,124.67) (614.69) (453.10) (29.75) (8.60)
Capex 0.00 (40.64) (8.96) (280.16) 0.00 (1,239.24) 388.14 266.79 0.00 0.00
Free cash flow (0.11) (1,674.73) (2,299.09) (2,644.96) (2,849.68) (3,363.91) (226.55) (186.31) (29.75) (8.60)
Book value 0.43 6,378.86 10,663.13 10,730.72 (437.84) 5,172.39 932.83 51.98 41.10 14.35
Shares, m 24 0 0 0 0 0 0 0 0 0
Valuation, ×
Valuation, × P/E 8.93 8.93 8.93 0.00 0.00 0.00 0.00 0.00 0.00 —
P/S 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
P/B 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
EV/Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.05 —
EV/FCF 0.00 0.00 0.00 (0.91) (0.16) (0.09) 0.00 (0.21) (1.36) —
Cash, $m
Cash, $m Operating cash flow (3) (4) (5) (6) (11) (14) (7) (8) (2) (3)
Capex 0 0 0 (1) — (8) 4 5 — —
Free cash flow (3) (4) (5) (7) (11) (23) (2) (3) (2) (3)
Balance, $m
Balance, $m Working capital 5 12 23 18 (6) 24 1 4 3 9
Total debt 12 10 11 10 1 — 2 5 — 11
Net debt 12 10 8 9 1 0 0 4 0 4
Shareholders’ equity 10 14 25 27 (2) 35 10 1 3 5
Returns, %
Returns, % ROA 31.85 15.33 10.26 (8.50) (87.52) 8.54 (116.86) (175.14) (127.85) (193.76)
ROIC 0.00 18.24 11.78 (4.58) 0.00 (11.07) (172.82) (206.71) (60.15) (100.81)
ROE 27.80 31.19 22.63 (18.99) (361.88) 19.61 (125.64) (313.89) (320.77) (595.11)
Negative figures in brackets.

All 10 years →

Fiscal years to Jun 2025 · fundamentals updated 2 Oct 2026

Charts ten years each

SANGRIX Inc. vs peers in Financial Data & Stock Exchanges (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
MSCI MSCI Inc $41.8B 31.1× 30.8× +12.20% (above 0%: growing) +19.90% (above 0%: growing) +8.19% (above 0%: growing) 82.71% 56.23% Compare
CBOE Cboe Global Markets, Inc. $32.2B 24.5× — +22.95% (above 0%: growing) +50.67% (above 0%: growing) −270.85% (below 0%: shrinking) 50.71% 32.99% Compare
TRU TransUnion $14.2B 19.3× 17.1× +14.91% (above 0%: growing) +33.93% (above 0%: growing) +42.65% (above 0%: growing) 58.41% 19.70% Compare
FDS FactSet Research Systems Inc. $10.7B 20.6× 14.5× +6.33% (above 0%: growing) −15.94% (below 0%: shrinking) −0.46% (below 0%: shrinking) 48.59% 24.68% Compare
MORN Morningstar, Inc. $7.9B 19.5× 17.9× +9.60% (above 0%: growing) +35.07% (above 0%: growing) +96.31% (above 0%: growing) 63.92% 24.22% Compare
VALU Value Line, Inc. $412.8M 20.7× 12.6× −6.45% (below 0%: shrinking) −27.54% (below 0%: shrinking) −15.38% (below 0%: shrinking) 100.00% 12.76% Compare
MKTW MarketWise, Inc. $298.3M 19.4× 10.0× −5.18% (below 0%: shrinking) n/m +22.28% (above 0%: growing) 85.34% (5.61%) Compare
DTCX Datacentrex, Inc. $67.4M — (loss-making) — −0.77% (below 0%: shrinking) n/m +60.66% (above 0%: growing) 10.73% (250.61%) Compare
SGRX SANGRIX Inc. $1.3M — (loss-making) — (loss-making) −91.80% (below 0%: shrinking) −28,100.00% (below 0%: shrinking) −4,360.41% (below 0%: shrinking) (56.88%) 0.00%
Median of peers $9.3B 20.6× 15.8× +7.97% +26.92% +15.23% 61.17% 21.96%

All 15 Financial Data & Stock Exchanges stocks →

SANGRIX Inc. (SGRX) key facts

  • SANGRIX Inc. (SGRX) is a Financial Data & Stock Exchanges company in the Financial sector, listed on Nasdaq.
  • As of October 16, 2026, SGRX traded at $0.87, a market capitalization of $1.3 million.
  • Return on equity was −595.1% and debt-to-equity -8.00.
  • Its Piotroski F-score is 5 out of 9 for fiscal 2025.

Source: company filings (standardised) and stockrow calculations · fundamentals updated Oct 2, 2026.

SANGRIX Inc. (SGRX) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/SGRX · Data as of Oct 2, 2026 · For information only; not investment advice. · © 2026 stockrow.com